Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
AssigneeSami Labs Limited
InventorsMuhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
Life of this patent
Estimating the term…
Abstract
The antimicrobial effect of extracellular metabolite composition from Bacillus coagulans MTCC 5856 and composition comprising from about 61% w/w of thymol, about 38% of monolaurin and about 1% w/w of magnolol obtained from supercritical fluid extracts of Magnolia officinalis is described.
Claims2
A process of microbial growth control, said process comprising the step of bringing into contact a microbial cell with a preparation consisting of extracellular metabolites of probiotic bacterial strain Bacillus coagulans deposited under accession number MTCC 5856, prepared by partially purifying a culture supernatant of said Bacillus coagulans strain, combined with a composition comprising from about 61% w/w of thymol, about 38% w/w of monolaurin, and about 1% w/w of magnolol, thereby inhibiting the growth of said microbial cell.
Dependencies are inferred from the claim text.